- Home
- UBCP vs IFRX Comparison
UBCP vs IFRX Comparison
Compare UBCP & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- IFRX
- Stock Information
- Founded
- UBCP 1902
- IFRX 2007
- Country
- UBCP United States
- IFRX Germany
- Employees
- UBCP N/A
- IFRX 74
- Industry
- UBCP Major Banks
- IFRX Biotechnology: Pharmaceutical Preparations
- Sector
- UBCP Finance
- IFRX Health Care
- Exchange
- UBCP Nasdaq
- IFRX Nasdaq
- Market Cap
- UBCP 80.1M
- IFRX 93.5M
- IPO Year
- UBCP N/A
- IFRX 2017
- Fundamental
- Price
- UBCP $12.75
- IFRX $1.27
- Analyst Decision
- UBCP
- IFRX Strong Buy
- Analyst Count
- UBCP 0
- IFRX 5
- Target Price
- UBCP N/A
- IFRX $7.40
- AVG Volume (30 Days)
- UBCP 3.5K
- IFRX 721.7K
- Earning Date
- UBCP 10-31-2025
- IFRX 11-07-2025
- Dividend Yield
- UBCP 7.07%
- IFRX N/A
- EPS Growth
- UBCP N/A
- IFRX N/A
- EPS
- UBCP 1.28
- IFRX N/A
- Revenue
- UBCP $29,909,000.00
- IFRX $191,224.00
- Revenue This Year
- UBCP N/A
- IFRX N/A
- Revenue Next Year
- UBCP $5.59
- IFRX $1,216.24
- P/E Ratio
- UBCP $10.20
- IFRX N/A
- Revenue Growth
- UBCP 0.94
- IFRX 54.36
- 52 Week Low
- UBCP $12.03
- IFRX $0.71
- 52 Week High
- UBCP $15.64
- IFRX $2.82
- Technical
- Relative Strength Index (RSI)
- UBCP 37.66
- IFRX 46.88
- Support Level
- UBCP $12.99
- IFRX $1.30
- Resistance Level
- UBCP $13.10
- IFRX $1.48
- Average True Range (ATR)
- UBCP 0.12
- IFRX 0.16
- MACD
- UBCP 0.02
- IFRX -0.01
- Stochastic Oscillator
- UBCP 0.00
- IFRX 22.81
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.